Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD1 | Q15139 | 14/20 | 0.77 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.49 |
| ▸ | PRKD2 | Q9BZL6 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | F10 | P00742 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6923082 | 1.00 | PRKD1 (0.77) | PRKD1PRKD3PRKD2NPC1POLB | |
| SCHEMBL935776 | 0.88 | PRKD1 (0.59) | PRKD1NPC1POLBRAB9AIRAK4 | |
| SCHEMBL1056918 | 0.87 | PRKD1 (0.76) | PRKD1NPC1POLBRAB9A | |
| SCHEMBL936600 | 0.87 | PRKD1 (1.00) | PRKD1PRKD3PRKD2 | |
| SCHEMBL936598 | 0.87 | PRKD1 (1.00) | PRKD1PRKD3PRKD2 | |
| SCHEMBL935870 | 0.79 | PRKD1 (0.79) | PRKD1PRKD3PRKD2 | |
| SCHEMBL935479 | 0.79 | PRKD1 (0.79) | PRKD1PRKD3PRKD2NPC1RAB9A | |
| SCHEMBL6922372 | 0.79 | PRKD1 (0.70) | PRKD1PRKD3PRKD2MAPTALDH1A1 | |
| SCHEMBL957994 | 0.79 | PRKD1 (0.81) | PRKD1PRKD3PRKD2MAPTALDH1A1 | |
| SCHEMBL958900 | 0.78 | PRKD1 (0.77) | PRKD1PRKD3PRKD2MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011009484-A1 | ARYLPYRAZOLES AND ARYLISOXAZOLES AND THEIR USE AS PKD MODULATORS | NOVARTIS AG (CH) | 2011-01-27 | — | — | WO | disclosed |
| WO-2011009484-A1 | ARYLPYRAZOLES AND ARYLISOXAZOLES AND THEIR USE AS PKD MODULATORS | NOVARTIS AG (CH) | 2011-01-27 | — | — | WO | disclosed |